Laboratory Fraud Evidence: When the Order and the Bill Tell Different Stories

Evidence of laboratory fraud connects what the practitioner ordered, why the patient needed it, what the laboratory performed, what the government paid and what anyone earned for sending the business. You may see a basic urine test become a molecular panel, a diagnosis appear only on the claim, or a commission rise with Medicare collections. The order, the bill and the payment can tell different stories about the same specimen. Your work may put you where those stories meet. Taxpayers foot the bill when Medicare and Medicaid pay for tests the practitioner never ordered.

What Evidence Is Needed to Prove Fraud?

The useful evidence connects a particular test to the clinical decision, the laboratory work, the claim and the people who controlled those decisions. Requisitions, results, billing records, compensation agreements and internal communications each answer a different part of that inquiry.

The business divides the information. The treating practitioner holds the patient history and reason for testing. The laboratory holds the order it received and the work it performed. A reference laboratory may do the actual testing, while another business submits the claim. Sales and finance hold the arrangements that brought the specimens through the door.

That separation explains why an insider’s knowledge matters. A billing employee may recognize that the claim has changed the order. A laboratory director may know what the instrument actually ran. A sales representative may know why a practice keeps sending the same broad panel. We connect those observations to the records behind the payment.

Who Ordered the Test?

The ordering evidence starts with the treating practitioner’s request and the requisition that reached the laboratory. Under Medicare’s diagnostic testing rule, the practitioner maintains the medical-necessity documentation, and the billing entity maintains the information it received and evidence that its claim accurately reflects it.

The version of the requisition matters. We compare the original request with the order entered into the laboratory system and the version used for billing. The added test, the date of the change, the person who made it and the practitioner’s authorization can connect a changed form to a changed claim. The original and revised forms let us see where the instruction changed hands.

For orders arriving through telemedicine companies or marketing call centers, we examine who selected the test, what contact the ordering clinician had with the patient and how the order reached the laboratory.

Standing-order renewals add another comparison. The Department of Health and Human Services Inspector General’s clinical-laboratory compliance guidance, published in 1998, calls for periodic monitoring, a fixed term of validity and renewal when a standing order expires. The original order, its renewal and the dates of later tests show which instruction the laboratory was relying on.

Do Lab Orders Need to Be Signed?

Medicare’s guidance permits unsigned clinical diagnostic test orders, but requires the physician to document the intent to order the test in the medical record. The chart supplies that intent. The requisition shows what the laboratory received. Reading them together puts the actual ordering decision in view.

Why Was the Panel Ordered?

Medical-necessity evidence connects each test to the patient’s condition and treatment. The diagnosis, clinical notes, selected tests and use of the results belong together. The Inspector General’s guidance specifically calls for requisitions that let practitioners make an independent medical-necessity decision about each test the laboratory will bill.

In the whistleblower’s complaint against Genova Diagnostics, the allegation was visible on the form itself. The complaint alleged that a single checkbox ordered NutrEval panels covering more than 100 test targets, without letting physicians deselect tests irrelevant to their patients. One check carried a very large order.

Whistleblowers brought the case against Physicians Choice Laboratory Services, and the government joined it. The government’s complaint alleged that a provider acknowledgment form put the physician’s signature on file and established a panel for every specimen unless the physician selected something different. Collectors allegedly attached preprinted, prechecked requisitions to the samples. The acknowledgment, requisition and collector’s work together show how a choice made when the account opened became testing repeated across its patients.

What Authorized the Added Test?

For reflex testing, the key comparison is the condition in the order and the initial result that triggered the additional test. Medicare’s ordering guidance allows a practitioner to request an additional test conditionally. The Inspector General’s guidance says the requisition should clearly state the condition under which the reflex test will run.

If a lab director discovers tests added without physician authorization, the original order, reflex instruction, initial result and later claim identify the decision to examine. The question is who selected the additional test and what patient-specific information supported that choice.

What Test Ran and What Result Came Back?

Performance evidence connects the specimen to the method, the performing laboratory, the underlying data and the reported result. We follow the specimen through the testing records, instrument output, repeat analyses and result revisions to examine the work behind the report.

This is where the laboratory director and quality staff can contribute knowledge that billing data lacks. Equipment and method records identify how the result was produced. Send-out records identify another laboratory’s part in the work. The report and its delivery to the practitioner connect that work back to the patient’s care.

Fat Finger, Falsification, or Fraud?, published in Spectroscopy Magazine in 2010, examines how laboratory data can be rewritten. Its example of a missing review signature makes the problem tangible: backdating a signature changes the apparent history of the review. The article argues for keeping original data, repeat analyses and a record of who changed information, when and why. The author describes how an auditor reads laboratory data.

A polished final report can leave the changes out of view. The original results and audit trail let us examine the decisions that produced the version the practitioner received.

Which Claim Paid?

The claim and payment records connect the test to the government money. The comparison includes the beneficiary, date of service, test code, billed units, ordering practitioner, performing laboratory, billing entity and amount paid. The code on a submitted claim and the code the payer reimbursed can each matter.

When a lab billing employee reports a discrepancy between an order and a billed panel, the order and claim for the same patient make the discrepancy concrete. In the complaint the government filed after joining the operations manager’s whistleblower case against Tomoka Medical Lab, an operations manager compared a Florida Medicaid claim for molecular testing with an order for basic urinalysis with culture and sensitivity. The government alleged another change on the same claim:

The complaint further alleged that the owner told the manager he had programmed the system to associate diagnoses with claims for the molecular tests. The comparison is how the manager allegedly spotted the change. The reported conversation identified how the system produced it. The Inspector General’s guidance separately addresses this exact billing practice, telling laboratories not to insert diagnosis codes automatically without diagnostic information from the ordering practitioner.

The Code, the Units and the Billing Entity

Unbundling separates a panel into component charges to increase payment. Duplicate billing charges again for a service already billed. The Inspector General’s guidance gives a concrete example of double billing: charging for a calculated result as well as the underlying tests used to calculate it.

Billed units call for comparison with the tests performed. A claim for an unperformed test calls for the specimen and performance records. A send-out requires the records of the laboratory that actually did the work.

Medicare generally pays the laboratory that performed or supervised the test, with specified exceptions for arrangements including some send-outs. We examine the performing and billing entities together with the payment arrangement.

Do Doctors Get Kickbacks for Ordering Tests?

Doctors and their practices have allegedly received cash and free goods in exchange for test referrals. The evidence connects what the practice received to the testing business it sent.

The Inspector General’s 2014 alert on laboratory payments to referring physicians identifies arrangements worth that comparison: payments tied to specimen or test volume, payments for work already reimbursed by Medicare, and processing fees paid to a practice when a laboratory-supplied phlebotomist actually performed the work.

The person collecting the specimen can know who did that work. The invoice shows who charged for it. The payment ledger shows who received the money. Put together, they can expose a practice being paid for a service someone else provided.

What Does the Commission Calculation Reward?

A laboratory sales representative can connect evidence of referral volume to the commission calculation through the compensation agreement, account activity, collections and payment records. The useful comparison identifies the payer, recipient, period, calculation and business the payment rewarded.

The government’s Physicians Choice complaint alleged a contract that paid a practice manager commissions based partly on a percentage of Medicare collections from specified practices’ samples. The alleged formula linked the referral source, the laboratory’s reimbursement and the manager’s payment. The agreement and collections records explain what earned the commission. The orders and claims explain the testing that generated it.

Free staff, supplies and equipment also carry value. Rent and service agreements add questions about the space used and work performed. We compare those benefits with the contracts, activity records and referral business, so the examination follows what the arrangement actually delivered.

Which of the Following Is a Red Flag for Healthcare Fraud?

A diagnosis appearing only on the claim, a broad panel repeated across patients, and compensation rising with referral collections are patterns worth examining. The underlying orders, patient records and payment arrangements show how each pattern arose.

The Inspector General’s guidance describes comparing ordering and billing patterns over time and investigating significant departures from a baseline. Repetition helps locate the decision that keeps producing the claims: a default panel, a billing instruction or a compensation formula. We connect that pattern to the specific records and people behind it.

What Proof Do You Need as a Whistleblower?

Your firsthand knowledge can supply the starting point, even if you see only one part of the laboratory’s work. Start with what you saw. We work through questions about access to records with you. A billing employee sees the submitted claim. A sales representative sees the account targets and commission calculation. A collector sees the specimen and requisition. A director or quality employee understands the test method and changes to the result.

An ordering-practice employee may know what the practitioner requested and whether the result came back. A compliance officer may know who received the warning and who decided to continue. The Tomoka operations manager’s alleged comparison shows why the job matters: it puts the person beside a particular decision or document.

We work with you to connect that knowledge to a laboratory fraud case. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

How to Detect and Deter Laboratory Fraud?

Order-to-claim reviews and independent checks of laboratory data can expose the decisions behind a false bill. Audit findings and management’s response show whether the laboratory corrected the problem.

When a lab compliance officer records management’s refusal to stop testing, the warning, response and continuing claims connect notice to the decision that followed. The Physicians Choice complaint alleged that an outside auditor repeatedly recommended changes to the custom-panel program. It quoted the auditor’s later report:

The government also alleged that compliance officials sought the changes and sales management opposed them. The auditor had identified a problem. The alleged response explains who controlled whether it was corrected.

What Corporate Integrity Reports Can Show

Precision Toxicology’s corporate integrity agreement with the Inspector General requires records of financial arrangements, who approved them and the payments made. Its required claims-review spreadsheet connects the federal health care program billed, service date, submitted code, reimbursed code and payment. Compliance review reports, the board’s responses and corrective-action plans must go to the Inspector General. For an insider, those records connect the finding to management’s response and what the laboratory did afterward.

When You Know Where the Records Diverge

If your work shows you why the laboratory’s order, result or bill tells a different story, speak to one of our Whistleblower Experts about the evidence you know. We build your strongest laboratory fraud whistleblower case with you around the testing decisions, government payments and people directing the business. We bring in laboratory fraud whistleblower lawyers who understand clinical billing and referral arrangements, and stay beside you through the case.